Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Trial record 3 of 24425 for:    DOLORES

The Efficacy of Pain Management With Self-reporting Pain Monitoring System in Cancer Patient (pain)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified April 2017 by The Catholic University of Korea
Sponsor:
Information provided by (Responsible Party):
DERSHENG SUN, The Catholic University of Korea
ClinicalTrials.gov Identifier:
NCT03117075
First received: January 19, 2016
Last updated: April 12, 2017
Last verified: April 2017
  Purpose
To compare the pain scales between clinician evaluated and reported with wearable device by patients.

Condition Intervention
Pain
Device: using device for scoring pain scale, named "ANAPA®"

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: No masking
Primary Purpose: Supportive Care
Official Title: The Efficacy of Pain Management With Self-reporting Pain Monitoring

Further study details as provided by The Catholic University of Korea:

Primary Outcome Measures:
  • Actual difference of pain scales [ Time Frame: 1 week after using wearable pain scale device - baseline and 1 week. ]
    comparing the pain scale assessed by wearable device and that assessed by physician when out patient clinic.


Estimated Enrollment: 68
Anticipated Study Start Date: May 15, 2017
Estimated Study Completion Date: April 14, 2018
Estimated Primary Completion Date: November 14, 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Experimental
using device for scoring pain scale, named "ANAPA®"
Device: using device for scoring pain scale, named "ANAPA®"
wearable device for scoring pain scale

Detailed Description:
To compare the pain scales between clinician evaluated and reported with wearable device by patients with cancer of advanced stage.
  Eligibility

Ages Eligible for Study:   20 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • over 20 year old
  • cancer pain with visual analog scale or numeric rating scale score >/- 4
  • opioids candidates
  • with informed consent form

Exclusion Criteria:

  • life expectancy within 3 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT03117075

Contacts
Contact: DERSHENG SUN, MD, PhD +82-31-820-3584 ds-sun@hanmail.net
Contact: HYESUNG WON, MD, PhD +82-31-820-5247 woncomet@catholic.ac.kr

Locations
Korea, Republic of
Daejeon St. Mary's Hospital, the Catholic University of Korea Active, not recruiting
Daejeon, Korea, Republic of
Seoul St. Mary's Hospital, the Catholic University of Korea Active, not recruiting
Seoul, Korea, Republic of, 06591
Sponsors and Collaborators
DERSHENG SUN
Investigators
Principal Investigator: YOONHO KO, MD, PhD Uijeongbu St. Mary's Hospital, the Catholic University of Korea
  More Information

Responsible Party: DERSHENG SUN, clinical assistant professor, The Catholic University of Korea
ClinicalTrials.gov Identifier: NCT03117075     History of Changes
Other Study ID Numbers: XC15EIMI0099KUD
Study First Received: January 19, 2016
Last Updated: April 12, 2017
Individual Participant Data  
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by The Catholic University of Korea:
cancer pain, wearable device

ClinicalTrials.gov processed this record on April 28, 2017